Suppression of acute rejective response following orthotopic liver transplantation in experimental rats infected with echinococcus multilocularis

Chinese Medical Journal

Volumn 124, Issue 18, 2011, Pages 2818-2823

  Li, Tao ^a   Zhao, Jin Ming ^a   Zhang, Yan ^a   Pai, Zu La ^a   Zhang, Wei ^a   Tuer Hongjiang, Tuxun ^a   Bai, Lei ^a   Wu, Jiang ^a   Wen, Hao ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Alveolar echinococcosis; Echinococcus multilocularis; Orthotopic liver transplantation;

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FRACTALKINE; INTERLEUKIN 10; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BROWN NORWAY RAT; CD28+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; ECHINOCOCCUS MULTILOCULARIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GERBIL; GRAFT RECIPIENT; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LEWIS RAT; LIVER GRAFT REJECTION; LIVER HYDATID CYST; LIVER PARENCHYMA; LIVER TRANSPLANTATION; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD28; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ECHINOCOCCOSIS, HEPATIC; ECHINOCOCCUS MULTILOCULARIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT REJECTION; INTERLEUKIN-10; LIVER TRANSPLANTATION; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80052975508     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.18.004     Document Type: Article

References (21)

1. Bresson-Hadni S, Koch S, Miguet JP, Gillet M, Mantion GA, Heyd B, et al. Indications and results of liver transplantation for Echinococcus alveolar infection: an overview. Langenbecks Arch Surg 2003; 388: 231-238.
2. Vuitton DA, Gottstein B. Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay. J Biomed Biotechnol 2010; 2010: 1-14.
3. Bresson-Hadni S, Blagosklonov O, Knapp J, Grenouillet F, Sako Y, Delabrousse E, et al. Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study. Liver Transpl 2011; 17: 855-865.
4. Kamada N, Calne RY. Orthotopic liver transplantation in the rat: technique using cuff for portal vein anastomsis and biliary drainage.Transplantation 1979; 28: 47-50.
5. Williams JW, Peters TG, Vera SR, Britt LG, van Voorst SJ, Haggitt RC. Biopsy-directed immunosuppression following hepatic transplantation in man. Transplantation 1985; 39: 589-596.
6. Lipscomb MF, Masten BJ. Dendritic cells: immune regulators in health and disease. Physiol Rev 2002; 82: 97-130.
7. Dengler TJ, Szabo G, Sido B, Nottmeyer W, Zimmerman R, Vahl CF, et al. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation. Transplantation 1999; 67: 392-398.
8. Hubner MP, Manfras BJ, Margos MC, Eiffler D, Hoffmann WH, Schulz-Key H, et al. Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients. Clin Exp Immunol 2006; 145: 243-251.
9. Godot V, Harraga S, Deschaseaux M, Bresson-Hadni S, Gottstein B, Emilie D, et al. Increased basal production of interleukin-10 by peripheral blood mononuclear cells in human alveolar echinococcosis. Eur Cytokine Netw1997; 8: 401-408.
10. Emery I, Liance M, Deriaud E, Vuitton DA, Houin R, Leclerc C. Characterization of T-cell immune responses of Echinococcus multilocularis-infected C57BL/6J mice. Parasite Immunol 1996; 18: 463-472.
11. Li J, Lai X, Liao W, He Y, Liu Y, Gong J. The dynamic changes of Th17/Treg cytokines in rat liver transplantrejective response and tolerance. Int Immunopharmacol 2011; 11: 962-967.
12. Bharat A, Fields RC, Trulock EP, Patterson GA, Mohanakumar T. Induction of IL-10 suppressors in lung transplant patients by CD4 25 regulatory T cells through CTLA-4 signaling. J Immunol 2006; 177: 5631-5638.
13. Waldmann H, Chen TC, Graca L, Adams E, Daley S, Cobbold S, et al. Regulatory T cells in transplantation. Semin Immunol 2006; 18: 111-119.
14. Cobbold SP. Regulatory T cells and transplantation tolerance. J Nephrol 2008; 21: 485-496.
15. Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine dependent mechanisms. J Exp Med 2003; 197: 111-119.
16. Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nature Immunol 2002; 3: 756-763.
17. Bazan JF, Bacon KB, Hardiman G, Wang W, So K, Rossi D, et al. A new class of membrane bound chemokine with a CX3C motif. Nature 1997; 385: 640-644.
18. Umehara H, Bloom ET, Okazaki T, Nagano Y, Yoshi O, Imai T. Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol 2004; 24: 34-40.
19. Meng KW, Song ZW, Zhou XT, Xu Z, Huang QX, Li SJ, et al. The significance and expresssion of fractalkine in acuterejective response after rat orthotopic liver transplantation. Chin J Reparat Reconstruct (Chin) 2007; 21: 528-531.
20. Haskell CA, Hancock WW, Salant DJ, Gao W, Csizmadia V, Peters W, et al. Targeted deletion of CX (3) CR1 reveals a role for fractalkine in cardiac allograftrejective response. J Clin Invest 2001; 108: 679-688.
21. Nicod L, Bresson-Hadni S, Vuitton DA, Emery I, Gottstein B, Auer H, et al. Specific cellular and humoral immune responses induced by different antigen preparations of Echinococcus multilocularis metacestodes in patients with alveolar echinococcosis. Parasite 1994; 1: 261-270.